Chemed officer proposes $1.07M share sale

The notice lists three earlier 2,000-share sales by Kevin J. McNamara in August and September 2026.

Rhea-AI Filing Summary

Chemed Corporation officer Kevin J. McNamara reported a proposed sale of 2,000 common shares, with an aggregate market value of $1,072,260 and an approximate sale date of September 28, 2026. Merrill Lynch is listed as the broker. The notice also lists prior sales of 2,000 shares each on August 3, August 21, and September 17, 2026.

Key Figures

Proposed sale: 2,000 common shares Aggregate market value: $1,072,260 Shares outstanding: 13,069,961 shares +3 more

6 metrics

Proposed sale 2,000 common shares Approximate sale date September 28, 2026

Aggregate market value $1,072,260 Proposed sale

Shares outstanding 13,069,961 shares Chemed Corporation common shares

Gross proceeds $1,079,024 Sale on August 3, 2026; 2,000 shares

Gross proceeds $1,082,324 Sale on August 21, 2026; 2,000 shares

Gross proceeds $1,002,789 Sale on September 17, 2026; 2,000 shares

Key Terms

Rule 144, Stock Award, Stock Exercise

3 terms

Rule 144 regulatory

"definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Stock Award financial

"Stock Award | Chemed Corporation"

Stock Exercise financial

"Stock Exercise Common"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What prior sales by CHE officer Kevin McNamara are listed?

Kevin J. McNamara sold 2,000 shares on August 3, 2026, for $1,079,024; 2,000 shares on August 21, 2026, for $1,082,324; and 2,000 shares on September 17, 2026, for $1,002,789.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/28/2026 - 03:28 PM Accepted by SEC EDGAR 09/28/2026 - 03:26 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001207137
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Chemed Corporation
SEC File Number	001-08351
Address of Issuer	255 E 5th St Suite 2600 Cincinnati OHIO 45202
Phone	513-762-6690
Name of Person for Whose Account the Securities are To Be Sold	Kevin McNamara
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 5905 E Galbraith Rd Suite 7000 Cincinnati OH 45236	2000	1072260	13069961	09/28/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/30/2023	Stock Awared	Chemed Corporation			1735	10/30/2023	Stock Exercise
Common	02/14/2025	Stock Award	Chemed Corporation			265	02/14/2025	Stock Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kevin J McNamara 255 E 5th St Suite 2600 Cincinnati OH 45202	Chemed Corporation	08/03/2026	2000	1079024
Kevin J McNamara 255 E 5th St Suite 2600 Cincinnati OH 45202	Chemed Corporation	08/21/2026	2000	1082324
Kevin J McNamara 255 E 5th St Suite 2600 Cincinnati OH 45202	Chemed Corporation	09/17/2026	2000	1002789

144: Remarks and Signature

Remarks
Date of Notice	09/28/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Marsha L Conley
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)